Kepler Capital Markets set a €48.50 ($59.88) target price on Carl Zeiss Meditec (ETR:AFX) in a research report sent to investors on Monday. The brokerage currently has a neutral rating on the stock.

AFX has been the subject of several other reports. Deutsche Bank set a €40.00 ($49.38) target price on Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Friday, December 1st. Berenberg Bank set a €55.00 ($67.90) target price on Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Friday, January 12th. Nord/LB set a €60.00 ($74.07) target price on Carl Zeiss Meditec and gave the stock a buy rating in a research note on Tuesday, December 12th. Independent Research set a €54.00 ($66.67) target price on Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Friday, December 8th. Finally, Commerzbank set a €42.00 ($51.85) target price on Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Friday, December 8th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of Hold and an average price target of €52.88 ($65.28).

Carl Zeiss Meditec (ETR:AFX) opened at €49.52 ($61.14) on Monday. Carl Zeiss Meditec has a one year low of €36.56 ($45.14) and a one year high of €55.25 ($68.21). The company has a market capitalization of $4,450.00 and a price-to-earnings ratio of 31.54.

ILLEGAL ACTIVITY WARNING: This news story was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://theolympiareport.com/2018/02/13/kepler-capital-markets-analysts-give-carl-zeiss-meditec-afx-a-48-50-price-target.html.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.